Are you Dr. Tschetter?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 25 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1020 W 18th St
Sioux Falls, SD 57104Phone+1 605-328-8000Fax+1 605-328-8001
Summary
- Dr. Loren Tschetter, MD is an oncologist in Sioux Falls, South Dakota. He is currently licensed to practice medicine in South Dakota.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1969 - 1972
Via Christi Hospital on St. FrancisInternship, Transitional Year, 1968 - 1969
University of Kansas School of MedicineClass of 1968
Certifications & Licensure
SD State Medical License Active through 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Clinical Trials
- Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Start of enrollment: 2006 Sep 15
- L-Arginine Supplements in Treating Women Who Are Cancer Survivors Start of enrollment: 2007 May 01
Publications & Presentations
PubMed
- 4 citationsPhase II Trial of Paclitaxel/Cisplatin Followed by Surgery and Adjuvant Radiation Therapy and 5-Fluorouracil/Leucovorin for Gastric Cancer (ECOG E7296).A. Bapsi Chakravarthy, Paul J. Catalano, Joshua K. Mondschein, David I. Rosenthal, Daniel G. Haller
Gastrointestinal Cancer Research. 2012-11-01 - 118 citationsTetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment G...Aminah Jatoi, Kendrith M. Rowland, Jeff A. Sloan, Howard M. Gross, Paul A. S. Fishkin
Cancer. 2008-08-15 - 23 citationsPaclitaxel, carboplatin, 5-fluorouracil, and radiation for locally advanced esophageal cancer: phase II results of preliminary pharmacologic and molecular efforts to m...Aminah Jatoi, James A. Martenson, Nathan R. Foster, Howard L. McLeod, Bradley S. Lair
American Journal of Clinical Oncology. 2007-10-01
